A new VC firm founded in 2017 and based in the Mid-Atlantic region of the USA is actively looking for post-seed investment opportunities in which the firm’s partners can contribute significant value. The size of investment will vary on a case-by-case basis. Currently, the firm will only consider companies that are based in the USA.
The firm is most interested in medical devices and healthcare IT/digital health/AI in healthcare start-up companies with a unique, high-growth potential product or technology. The firm is highly interested in surgical devices that can dramatically improve outcomes in healthcare systems. Ideally, these companies should have broad IP protection and have existing first paying customers. The firm will not consider opportunities in the therapeutics sector.
The firm will evaluate investment opportunities based on a proprietary scoring model, which includes the company’s market size/niche, growth potential, management team, exit potential, etc. The firm will expect to see management teams with strong expertise in their company’s relevant sectors, as well as a strong business model. The firm will always take a board seat and one of the firm’s general partners will act as an entrepreneur-in-residence (EIR), taking an active role by serving as an advisor and providing project-specific expertise. The firm can act as the lead investor or co-invest with other funds.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com
Leave a Reply